Dual Mechanism of Severe Bleeding Diathesis in a Patient with CLL: Acquired Von Willebrand Syndrome and Ibrutinib - Mediated Platelets Dysfunction

Bürki, S; Novak, U (2020). Dual Mechanism of Severe Bleeding Diathesis in a Patient with CLL: Acquired Von Willebrand Syndrome and Ibrutinib - Mediated Platelets Dysfunction. Annals of Hematology & Oncology, 7(3) Austin Publishing Group

[img]
Preview
Text
hematology-v7-id1290.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (3MB) | Preview

We here report an informative case of severe bleeding diathesis in a patient with Chronic Lymphocytic Leukaemia (CLL), due to Acquired Von Willebrand Syndrome (AVWS) and impaired platelets aggregation under the treatment with Ibrutinib.
Keywords: CLL; Acquired von Willebrand syndrome; Ibrutinib; Bleeding

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

UniBE Contributor:

Bürki, Susanne and Novak, Urban

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2375-7965

Publisher:

Austin Publishing Group

Language:

English

Submitter:

Rebeka Gerber

Date Deposited:

29 Sep 2020 12:26

Last Modified:

29 Sep 2020 15:55

BORIS DOI:

10.7892/boris.146722

URI:

https://boris.unibe.ch/id/eprint/146722

Actions (login required)

Edit item Edit item
Provide Feedback